The SHV-β-lactamases comprise one of the most clinically significant classes of β-lactamase family. PCR and hybridisation studies revealed that bla SHV genes are native to K. pneumoniae chromosome (Ford and Avison, 2004) . It has also been found on plasmids of K. pneumoniae and some other members of Enterobacteriaceae family such as E. coli, K. oxytoca and Proteus mirabilis (Hirakata et al., 2005) . SHV-1 is encoded both chromosomally and on plasmids in K. pneumoniae. SHV-β-lactamases belong to group 2be β-lactamases. Since SHV-β-lactamase gene is a normal part of the K. pneumoniae chromosome, evidences have shown that plasmid-borne bla SHV genes are originated from chromosomal bla SHV genes as a result of translocation via transposons and insertion sequences such as insertion sequence 26 (IS26). The plasmid borne bla SHV carries IS26 insertions (820 bp IS) either upstream of the promotor or in it, which in turn reinforces the promotor strength. The aim of the present study was PCR amplification of SHV-11 gene genomic DNA and SHV-12 gene in plasmid DNA in of the phenotypic ESBL producer and phenotypic non-ESBL producer isolates of K. pneumoniae in order to know whether presence of these genes related to antibiotic resistance or not.
2.MATERIALS AND METHODS

BACTERIAL SAMPLES
Three-hundred and fifty urine samples were collected during the period of 2nd of June to 5th of October 2012 from patients with urinary tract infection admitted to Hawler Teaching, Rizgary, Raparin and West Emergency hospitals in Erbil city.
Urine samples were cultured on MacConKey agar by streaking method and incubated at 37˚C for 18-24 hours. The suspected colonies were sub-cultured on nutrient agar for obtaining pure culture.
The morphological characteristics of the colonies were studied. The K. pneumoniae isolates grow well on ordinary media at 37˚C for 18-24 hours. On MacConkey agar the colonies typically appear large, pink and mucoid (Arora and Arora, 2008) . The biochemical tests performed for suspected bacterial isolates include catalase, oxidase, urea hydrolysis, citrate utilization, sugar fermentation and motility tests (Atlas et al., 1995) . Moreover, VITEK 2 was used for confirming the identity of the isolates.
DETECTION METHODS FOR ESBLS 2.2.1 PHENOTYPIC DETECTION METHODS
With rising in number of ESBL producing clinical isolates of bacteria there is also requirement for their detection in the laboratory (Al-Jasser, 2006) . According to the Clinical and Laboratory Standards Institute (CLSI, 2011) guidelines for detection of ESBL-production, an initial screening method and phenotypic confirmatory tests based on synergy between an indicator cephalosporin and clavulanic acid was used.
Although these three antibiotic discs (CTX, CI and ATM) were used as indicator of ESBL production as the antibiotic sensitivity testing was done, phenotypic confirmatory tests was done for all of the isolates.
According to the CLSI, (2011) recommendations, a disc of ceftazidime (30μg) alone and in combination with clavulanic acid (30/10μg) discs were used. The discs were placed on a plate streaked with the isolate to be tested within fifteen minutes. An increase of 5 mm or more in the zone diameter of ceftazidime tested in combination with clavulanic acid versus its zone when tested alone, confirm the presence of ESBL phenotype.
DOUBLE DISC SYNERGY TEST (DDST)
In the same way as the antibiotic sensitivity testing was done, a disc of amoxicillin/clavulanic acid (20/10μg) placed 16 mm apart (centre to centre) from a disc containing a third generation cephalosporin (cefotaxime, ceftriaxone and aztreonam) on a plate of Muller-Hinton inoculated and streaked with the tested bacterium. Extension of the edge of one of the cephalosporins or aztreonam zone on the side exposed to the disc containing clavulanic acid indicate the presence of ESBL and the isolate should be considered as ESBL producer (Freitas et al., 2003) .
COMBINATION DISC METHOD (CDM)
MOLECULAR DETECTION METHOD
Since the phenotypic ESBL detection methods do not provide an accurate identification of an ESBL producer, detection of the β-lactamase gene is a more precise approach. In this study, specific primers were designed for amplification of SHV-11 which is a non-ESBL β-lactamase gene and SHV-12 which is an ESBL β-lactamase gene. PCR was done for genomic DNA extracts of all fifty isolates by using SHV-11 primers and plasmid DNA extracts by using SHV-12 primers.
GENOMIC DNA EXTRACTION
The G-spin ™ genomic DNA extraction kit was used for purification of genomic DNA of the isolates. It is designed for rapid isolation of genomic DNA from a variety of sample sources.
Plasmid DNA extraction
Plasmid DNA was extracted from 5 millilitre (ml) of an overnight culture of the isolates of K. pneumoniae grown in LB broth medium containing an appropriate antibiotic by using plasmid DNA purification kit (DNA-spin Plasmid DNA Purification Kit/ iNtRON/ Korea). The extracted plasmid DNA was stored at -20 o C until using.
PCR AMPLIFICATION OF BLASHV -11 AND BLASHV -12 GENES
Specific oligonucleotide primers were designed for SHV-11 and SHV-12 genes according to bla and bla SHV-12 nucleotide sequences by using Genius software. For running PCR products of both SHV-11 and SHV-12, 1.2 gm agarose powder was weighed and added to 100 ml of TBE buffer and bring to boil. After cooling, the gel casted and after solidification, the PCR products were loaded into the wells in the gel, 5µl/well. Five µl of 1500bpDNA ladder (Gene Direx) loaded into one of the wells in the gel to determine the size of the amplified products. The gels were run at 45V/15 min., then at 135V/30-45min. The gel stained with ethidium bromide, visualised by UV-trans illuminator and photographed.
The method described by Sambrook and Russell, (2001) was used for gel electrophoresis. The extracted plasmids were electrophoresed in 0.7% agarose gel with TrisBorate Ethylene-Diamine Tetra-Acetic acid (TBE), stained with ethidium bromide and visualized under UV-light.
3.RESULTS AND DISCUSSION
Among 350 urine samples collected from patients admitted to Hawler Teaching, Rizgary, Raparin and West Emergency hospitals in Erbil city during the period of 2nd of June to 5th of October 2012, fifty isolates were identified as K. pneumoniae. The isolates of K. pneumoniae identified.On MacConkey agar, the colonies of K. pneumoniae are typically appear as large, mucoid and pink (figure1) with red pigment usually diffusing into the surrounding medium indicating fermentation of lactose and acid production (Winn et al., 2006) . All of the isolates were positive for citrate, catalase and urease tests, whereas, oxidase negative. They all ferment glucose and lactose and gave yellow slant and yellow butt (acidic/acidic) reaction, while H 2 S negative. Furthermore, they were non-motile. The identity of the isolates was confirmed by using Vitek2 system. The sheet of the results of identification by Vitek2 system is shown in the appendix. It shows that the isolates were identified as K. pneumoniae subsp. pneumoniae with probability of 99% which is considered as an excellent level of identification.
ESBL screening by disc diffusion method was done for all fifty K. pneumoniae isolates by using three antibiotic discs as screening agent which were CTX, CI and ATM according to CLSI, (2011) recommendations. Out of these fifty, thirty-four isolates (68%) were resistant to at least one of the three ESBL screening agents. Twenty-six (52%) of the isolates were resistant to all the three tested antibiotics, one isolate was resistant for CI and ATM, three isolates showed resistance against CTX and ATM, one isolate resistant for CTX and CI, one isolate resistant for ATM and CI, one of them resistant for CI and two isolates resistant for ATM alone. The present results agree with that of Shukla et al., (2004) who reported that 72% of the isolates were resistant to the 3GCs tested. However, they are incompatible with the results of Subha and Ananthan, (2002) who found that 87% of their isolates showed resistance to all the three 3GCs.
Extended-spectrum β-lactamases have been found in a wide range of Gram-negative bacteria and has emerged as an important mechanism of resistance in these bacteria. However, the major strains expressing these enzymes belong to the family Enterobacteriaceae (Ramazanzadeh, 2010) , K. pneumoniae remains as the major ESBL-producing organism isolated worldwide (Iroha et al., 2011) . In addition, over reliance on 3GCs for treatment of Gram negative infections is one of the prime factors responsible for increased resistance to this class of antibiotics. As ESBLs are frequently encoded by genes located on different transferrable genetic elements, a variety of epidemiological situations have been identified (Widmer, 2008 ).
Among fifty isolates tested to know whether they are ESBL producer or not by DDST, only four (8%) of them gave positive result. As it is shown in the figure (2), the synergy between a cephalosporin and clavulanic acid indicate a positive result. This result agrees with that of Subha and Ananthan, (2002) who reported that 6.66% of K. pneumoniae isolates are ESBL positive by DDST.Although DDST is considered as a reliable method for ESBL detection, it has been known to suffer from the non-standardization of the distance of disc placement (Tofteland et al., 2007) . Another reason may be AmpC enzymes which are induced by clavulanate (which inhibit them poorly) and may then attack the cephalosporins, masking synergy arising from inhibition of the ESBL (Pfaller and Segreti, 2006) . This can be a cause of disagreement of the current study with the previously mentioned ones, in addition to geographical differences. Out of fifty isolates tested for detection of ESBL production by CDM, twenty-one (42%) of them were confirmed as ESBL producer. An increase of 5 mm or more in the inhibition zone diameter for ceftazidime tested in combination with clavulanic acid versus its zone when tested alone, confirm the presence of ESBL phenotype ( figure 3) .
The present result is in agreement with that of Nasehi et al., (2010) who showed that 38.5% of their K. pneumoniae isolates had ESBL phenotype by this method. Among 52% of the isolates which were resistant to all three ESBL screening agents, twenty-five (50%) were confirmed as ESBL producer by both methods together, CDM identified (42%) alone and (8%) identified by DDST. It has been reported that 57.1% of K. pneumoniae were phenotypic ESBL producer based on phenotypic confirmatory tests, DDST and CDM which is in agreement with the current result (Taşli and Bahar, 2005) . The present result is in agreement with the study that was carried out by Fazly Bazzaz et al., (2009) who showed that the prevalence of ESBL producing K. pneumoniae was 61% by the phenotypic disc confirmatory tests. The overall high prevalence of ESBL-positive K. pneumoniae may be due to the lack of chromosomally encoded AmpC β-lactamases in the genus Klebsiella (Tofteland et al., 2007) .
Out of 25 phenotypic ESBL producer isolates in the present study, 17 (68%) resist all three tested screening agents, while only 9 (36%) of phenotypic ESBL negative isolates were resistant during ESBL screening test. The current results indicate that ESBL screening can be used for presumptive identification of potential ESBL producers among urinary isolates of K. pneumoniae.
The use of phenotypic tests for detection of ESBL producing microorganisms remains an issue, causing a great deal of discussion and controversy. Some factors such as production of different β-lactamases by the same microorganism could lead to erroneous conclusions (Sanguinetti, 2003) . Tests based on the detection of ESBLs by PCR are more conclusive in defining ESBL production (Steward, 2001) . Recently, molecular methods have been shown to be absolutely necessary to detect specific ESBL type (Taşli and Bahar, 2005) .
In this study SHV-11 which is a non-ESBL β-lactamase gene and SHV-12 which is an ESBL β-lactamase gene were amplified by using specific primers designed for them. PCR was done for genomic DNA extracts of all fifty isolates using SHV-11 primers and for their plasmid DNA extracts using SHV-12 primers.
After extraction of genomic DNA from all K. pneumoniae isolates by PCR and gel electrophoresis were carried out to screen and determine the presence of blaSHV-11 in the DNA of K. pneumoniae. PCR was performed on template DNA of each bacterial isolate separately for amplification of blaSHV-11 gene via the use of specified oligonucleotide primers that flanked DNA sequence to be amplified. After amplification of blaSHV-11 gene, PCR products of all bacterial samples were ran in agarose gel and visualised by UVtransilluminator to detect the presence of the gene.
The present results show that out of fifty isolates of K. pneumoniae, forty-six (92%) contain blaSHV-11 gene in their genomic DNA. Although, all isolates in the current study were resistant for ampicillin, only 92% possess blaSHV-11 in the genomic DNA. This suggests that ampicillin resistance in those isolates which lack blaSHV-11 in their genomic DNA may be due to blaSHV-1 or plasmid encoded blaSHV-11, because blaSHV-1 which is the ancestor of blaSHV-11 is responsible for about 20% of plasmid encoded ampicillin resistance in K. pneumoniae (Tzouvelekis and Bonomo, 1999) . Moreover, this result is compatible with that of Younes, (2010) who stated that only 90% (54/60) of tested K. pneumoniae in his study were positive by PCR for SHV genes, despite expectation that K. pneumoniae isolates present an intrinsic resistance to ampicillin (Heritage et al., 1999) . Similar resistance findings reported that 95% (178/187) of K. pneumoniae isolates collected from Portugal showed reduced susceptibility to ampicillin had blaSHV (Mendonça, 2009) . Ozdemir et al., (2013) showed that the gene which was responsible for resistance to AMP reside in a 5000 bp mobile DNA segment which had the ability to translocate itself. The figure (4) shows the results of PCR amplification of blaSHV-11 of the phenotypic ESBL positive K. pneumoniae UTI isolates. After running of PCR products in agarose gel, the isolates which gave positive result in PCR, produced a band of 463 bp, which indicated the presence of blaSHV-11 gene. Among phenotypic ESBL producer isolates, blaSHV-11 found in the genomic DNA of twenty-four (96%) of the isolates.
The present result is similar to that of Ghafourian et al., (2011) who reported that among 67 phenotypic ESBL producer isolates of K. pneumoniae, PCR amplification of blaSHV gene in genomic DNA was positive in 94% of the isolates. It has also been shown that 100% of phenotypic ESBL producer isolates of K. pneumoniae had blaSHV gene in their genomic DNA by PCR amplification (Tribuddharat et al., 2007) .
Among phenotypic ESBL negative isolates of K. pneumoniae, twenty-two (88%) contained blaSHV-11 in their genomic DNA as shown in the figure (5). (2010) who demonstrated that blaSHV-11 was the most prevalent gene described in his study, blaSHV-11 was highly prevalent in the current investigation and among 25 phenotypic ESBL negative isolates 23 isolates possess blaSHV-11. Moreover, out of 21 isolates included in the study of Lee et al., (2006) seventeen isolates contain blaSHV-11 alone and associated with blaSHV-12 in 4 isolates. The blaSHV-11 has been described most often in K. pneumoniae (NueschInderbinen et al., 1997) and may be the ancestor of blaSHV-2a and blaSHV-12 (Ford and Avison, 2004) . The non-ESBL phenotype conferred by SHV-11 shows that the Leu35Gln substitution between SHV-11 and SHV-1 has little or no significance with respect to hydrolysis of expanded-spectrum cephalosporins, therefore, its appearance is likely to be due to drift rather than antibiotic selection (Howard, et al. 2002) .
In addition, the result of the present study is in concordance with that of Oliveira et al., (2010) who performed PCR for genomic DNA of all isolates in their study and found that SHV genotype was present in 78.1% of the K. pneumoniae isolates.
PCR amplification of blaSHV-12 gene was performed for plasmid DNA extracts of all of the isolates by using specific oligonucleotide primers. Among fifty isolates, twenty-nine (58%) had blaSHV-12 gene in their plasmids. Among blaSHV-carrying ESBL producer K. pneumoniae isolates, 51.4% of the genes encoded non-ESBL SHV-11, while the rest produced SHV-type ESBLs, including SHV-12 (34.6%) (Kiratisin et al., 2008) . This is disagree with the results of the present study which may be due to that PCR amplification was done only for ESBL positive isolates in their study.
Among phenotypic ESBL producer isolates, 72% had blaSHV-12 in their plasmid DNA and gave a band of 461 bp, whereas 24% (6 isolates) lack the gene (figure 6). This absence of blaSHV-12 and presence of ESBL phenotype could be attributed to hyper production of non-ESBL β-lactamases, SHV-1 or SHV-11, due to high gene copy number or a single base pair change in promoter sequence, or modifications in outer membrane proteins co-existing with TEM-1, SHV-1 and SHV-11. These result in conferring an ESBL similar phenotype causing false positive results (Wu et al., 2001) . The presence of other types of ESBL genes could be counted as another reason for ESBL phenotype in these isolates The present findings are consistent with the study of Paterson et al., (2003) who demonstrated that SHV-type ESBLs were the most common ESBLs, occurring in 67.1% (49 of 73) of isolates of K. pneumoniae with phenotypic evidence of ESBL production. It is also agree with that of (Taşli and Bahar, 2005) . They detected SHV-type ESBLs in 74.3% of the isolates and among 18 sequenced SHV amplicons, 5 were SHV-12 (27.7%). Lin et al., (2010) and Severin et al., (2010) found that 100% and 65.3% of their phenotypic ESBL positive K.pneumoniae isolates had SHV type ESBL in their plasmid DNA. The latter showed that (27.6%) of SHV type ESBLs were of SHV-12 type.
Of the phenotypic ESBL negative isolates of K. pneumoniae included in the present study, eleven (44%) isolates contained blaSHV-12 in plasmid DNA, while the rest lack blaSHV-12 in their plasmid DNA (figure 7). 
Eighteen
(72%) isolates among phenotypic ESBL positive isolates contain blaSHV-11 gene in genomic DNA and blaSHV-12 gene in plasmid DNA. This is agreeing with the hypothesis that chromosomal copy of non-ESBL SHV is essential for expression of an ESBL phenotype. Lee et al., (2006) showed that K. pneumoniae strains carrying blaSHV-11 on the chromosome abundantly express plasmid-derived SHV-12, concluding that blaSHV-11 was transferred from the chromosome by an IS26 originating from a blaSHV-12 element which showed a direct relationship between IS26 and blaSHV. Furthermore, 4 isolates from 13 ESBL positive strains carried copies of a non-ESBL-encoding gene either blaSHV-1 or blaSHV-11 in addition to the blaSHV-2a or blaSHV12 gene (Howard et al., 2002) .
Six (24%) of the phenotypic ESBL positive isolates contain blaSHV-11 in genomic DNA, while lack blaSHV-12 in plasmid. This absence of blaSHV-12 in the plasmid and presence of ESBL phenotype can be attributed to other types of ESBLs or hyper production of blaSHV-11.
One (4%) of the phenotypic ESBL positive isolates lack both genes, which agree with that of Oliveira et al., (2010) in which nine isolates were positive for ESBL production by the phenotypic tests but gave negative result with PCR.
Among phenotypic ESBL negative isolates, eleven (44%) of isolates possess blaSHV-11 in genomic DNA and blaSHV-12 in plasmid DNA. Despite presence of blaSHV-12 in their plasmid DNA, these isolates were unable to give an ESBL phenotype. This can be attributed to the low level of the expression of that gene, which cannot give observable ESBL phenotype. This result agree with Oliveira et al., (2010) who reported that fifteen isolates possess the SHV family but gave negative ESBL phenotype.
Twelve (48%) of the phenotypic ESBL negative isolates contain blaSHV-11 in genomic DNA, while lack blaSHV-12 in plasmid DNA. This indicates that presence of blaSHV-12 in plasmid DNA is essential for giving a positive ESBL phenotype.
Two (8%) of the phenotypic ESBL negative isolates lack both genes in genomic and plasmid DNA, therefore, their negative phenotype may be due to absence of these genes. This is agree with that of Bali et al., (2010) , in which one of the positive isolates of K. pneumoniae with CDM had no ESBL with PCR. These isolates may have other types of ESBL. It has been shown that the majority (29/32) of K. pneumoniae isolates harbour transferable blaSHV whereas, a strain carry blaSHV-11 and contain the large SHV transposon was failed to conjugate with the recipient strain (Younes, 2010) . This indicated chromosomal location which agrees with other findings that the large SHV transposon is chromosomal location (Turner et al., 2009 ). Furthermore, a strain of K. pneumoniae possessed blaSHV-12 could not be transferred by conjugation indicating a non-conjugative plasmid location (Younes, 2010) .
Considering their plasmid profile, 40% of phenotypic ESBL positive isolates contained one plasmid, 56% possess two plasmids and one phenotypic ESBL positive isolate had four plasmids.
Conclusions
Phenotypic ESBL screening can be used for presumptive identification of potential ESBL producer isolates. High prevalence of phenotypic ESBL producers among Klebsiella pneumoniae urinary isolates. Both SHV-11 and SHV-12 genes are more prevalent in phenotypic ESBL producer isolates. Finally, presence of SHV-11 in genome and SHV-12 in plasmid DNA is necessary for phenotypic ESBL production.
